Paper852886
Artificial disaccharide-protein conjugates as immunogens for the preparation of specific anti-Salmonella O-antisera.
Ekborg G and 6 others. Immunochemistry, 1977. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Artificial disaccharide-protein conjugates as immunogens for the preparation of specific anti-Salmonella O-antisera. Papers, record 852886. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/852886
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artificial disaccharide-protein conjugates as immunogens for the preparation of specific anti-Salmonella O-antisera.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Bacterial | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Salmonella | Major topic |
| Animals | |
| Antibody Specificity | |
| Hemagglutination Tests | |
| Male | |
| Rabbits | |
| Serum Albumin, Bovine |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31158047 | Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human. | Hum Vaccin Immunother | 2019 | https://conductscience.org/library/papers/31158047 | PubMed |
| 17558551 | Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies. | Glycoconj J | 2008 | https://conductscience.org/library/papers/17558551 | PubMed |
| 7019072 | Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis. | Infect Immun | 1981 | https://conductscience.org/library/papers/7019072 | PubMed |
| 1723070 | Anti-Salmonella lipopolysaccharide monoclonal antibodies: characterization of Salmonella BO-, CO-, DO-, and EO-specific clones and their diagnostic usefulness. | J Clin Microbiol | 1991 | https://conductscience.org/library/papers/1723070 | PubMed |
| 387597 | Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. | Infect Immun | 1979 | https://conductscience.org/library/papers/387597 | PubMed |
| 327249 | Synthetic disaccharide-protein antigens for production of specific 04 and 09 antisera for immunofluorescence diagnosis of salmonella. | Med Microbiol Immunol | 1977 | https://conductscience.org/library/papers/327249 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/852886
GET https://conductscience.org/api/papers/v1/852886/authors